ArticleHuman vaccines & immunotherapeutics2016

An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1.

Julie L Dutton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.